May 20, 2013 – Although relationships between the pharmaceutical industry and physicians have come under greater scrutiny as the implementation date of the Sunshine Act final rule draws nearer, a recent article in The Atlantic states that critics of these relationships “have it backwards.” Indeed, the author asserts that advancing medical progress “requires, ideally, close communication between industry and outside experts,” and that “we should strive to cultivate, not demonize, these sorts of interactions.”
To read the full article, which provides a common-sense look at the “right” relationships between industry and physicians, go to:
